期刊文献+

CKD非透析患者CVD的发生情况及影响因素分析

下载PDF
导出
摘要 目的研究慢性肾脏病(CKD)非透析患心血管疾病(CVD)的发生情况及危险因素。方法分析695例cKD非透析患者基础资料、实验室指标、心脏彩色超声指标及其与既往CVD病史之间的关系,研究CKD非透析患者CVD的发生情况,探讨与其相关的危险因素。结果695例患者中226例(32.5%)有CVD既往史,Logistic回归分析显示,年龄、GFR、SBP、DBP、颈总动脉内径、颈总动脉IMT及分叉部IMT是cKD非透析患者CVD的独立危险因素。结论cKD非透析患者CVD的发生率较正常人显著升高,年龄、高血压、脂质代谢紊乱、微炎症状态、贫血、低蛋白血症、钙磷代谢紊乱等因素与CKD患者CVD的发生、发展密切相关。 Objects This study was designed to observe the prevalence of cardiovascular disease and its influencing factors in non-dialysis CKD patients. Method 695 CKD patients and 52 controls were enrolled in the present study. We investigated CVD morbidity through clinical data collection, laboratory tests, echocardiography. Results The morbidity of CVD was much higher in non-dialysis CKD patients. Many traditional and nontraditional cardiovascular risk factors may contribute to the excessive risk of CVD, such as age, hypertension, dyslipidemia, inflammation, anaemia, hypoproteinemia and secondary hyperparathyroidism. Conclution The prevalence of CVD is relatively high in CKD patients. Age, hypertension, lipid metabolism disorders, micro-inflammatory state, anemia, hypoproteinemia, calcium and phosphorus metabolism disorders are the independent risk factors for CVD in non-dialysis CKD patients.
出处 《浙江临床医学》 2012年第11期1329-1331,共3页 Zhejiang Clinical Medical Journal
关键词 慢性肾脏疾病 心血管疾病 非透析 chronic kidney disease cardiovascular disease Non-dialysis
  • 相关文献

参考文献10

  • 1Samak MJ,Levery AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension, 2003, 42(5): 1050-1065.
  • 2Henry RM, Kostense PJ, Bos G, et al.Mild renal insufficiency is associated with increased cardiovascular mortality:The Hoorn Study. Kidney Int,2002,62(4): 1402-1407.
  • 3Zebrack JS,Anderson JL,Beddhu S, et al. Do associations with C-reactive protein and extent of coronary artery disease account for the increased cardiovascular risk of renal insufficiency. J Am Coll Cardiol, 2003, 42(1): 57-63.
  • 4Descamps-Latscha B, Witko-Sarsat V, Nguyen-Khoa T, et al. Advanced oxidation protein products as risk factors for atherosclerotic cardiovascular events in nondiabetic predialysis patients. Am J Kidney Dis,2005,45(1):39-47.
  • 5Enia G, Panuccio V, Mallamaci F, et al. Fibrinogen and calcium x phosphate product are predictors of cardiovascular events in the CAPD population. J Nephrol, 2005,18(6):764-769.
  • 6Zoccali C, Mallamaci F, Tripepi G, et al. Fibrinogen,mortality and incident cardiovascular complications in end-stage renal failure. J Intern Med,2003,254(2): 132-139.
  • 7Weiner DE, Tighiouart H, Elsayed EF, et al. The relationship between nontraditional risk factors and outcomes in individuals with stage 3 to 4 CKD. AmJ Kidney Dis,2008,51(2):212-223.
  • 8Ma JZ, Ebben J, Xia H, et al. Haematocrit level and associated mortality in hemodialysis patients. J Am Soc Nephrol, 1999, 10(3): 610-619.
  • 9Menon V, Greene T,Wang X, et al. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int, 2005, 68(2): 766-772.
  • 10Cooper BA, Penne EL,Bartlett LH, et al. Protein malnutrition and hypoalburninemia as predictors of vascular events and mortality in ESRD. AmJ Kidney Dis, 2004, 43 (1) : 61-66.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部